FDA issued a Warning Letter to Medtronic, Inc. on 7/17/2012 for a previous inspection.
483 Medtronic Neuromodulation Apr 2013

483 Medtronic Neuromodulation Apr 2013

Jessica Johnson FDA, Susan Matthias FDA$119.00 - Available Now

FDA investigators audited the Medtronic Neuromodulation - Minneapolis, MN, United States facility and issued inspectional observations (via FDA 483) on 03 Apr 2013.

Product details

  • Category: Medical Devices & Rad Health
  • Inspection end: 03 Apr 2013
  • Location: Minneapolis, United States
  • FEI: 2182207
Add To Cart